We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Rules in Favor of AbbVie’s Humira Patent, Denying Coherus’ Challenge
PTAB Rules in Favor of AbbVie’s Humira Patent, Denying Coherus’ Challenge
The PTO’s Patient Trial and Appeal Board said it was not persuaded by Coherus Biosciences’ challenge over the patentability of methods for manufacturing Humira, and ruled in favor of AbbVie in a trial proceeding.